Gastro-Oesophageal Unit, Department of General Surgery, St. Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK.
Surg Endosc. 2012 Mar;26(3):811-7. doi: 10.1007/s00464-011-1957-x. Epub 2011 Oct 13.
An increasing number of minimally invasive oesophagogastrectomies (MIOG) are being performed. However, the complexity of the surgical skills required and the steep learning curve have thus far confined the minimally invasive approach to selected tertiary centres. The oesophagogastric and the oesophagojejunal anastomosis can be challenging and often time-consuming. The recently developed transorally inserted anvil (OrVil(™)) is a technique aimed to simplify the anastomotic procedure. The aim of the study was to evaluate the safety, feasibility, and efficacy of OrVil(™)-assisted anastomosis during laparoscopic surgery in a tertiary upper-GI cancer centre.
From July 2008 to July 2010, 53 consecutive patients underwent MIOG for cancer performed by one surgeon at our institution. Thirty patients underwent laparoscopic Ivor-Lewis oesophagectomy (ILO) and 23 patients underwent laparoscopic gastrectomy. Of the latter group, 13 had a total gastrectomy (TG) and 10 had a subtotal gastrectomy (SG). The gastrointestinal anastomosis was checked with intraoperative endoscopy in all cases.
There were three in-hospital deaths. Median hospital stay was 14 days for oesophagectomies and 11 days for gastrectomies. There were three anastomotic leaks (5.6%), all in the oesophageal group, successfully treated conservatively. Two patients needed conversion to open surgery (3.7%), 3 patients (5.6%) required re-exploration (for bleeding, infected haematoma, and diaphragmatic hernia), and 18 patients (34%) had respiratory complications (pneumonia, pleural effusions, respiratory failure). Four patients developed anastomotic stricture requiring endoscopic balloon dilatation. The average number of lymph nodes harvested was 22 (range = 11-39) and 26 (range = 5-78) for oesophagectomies and gastrectomies, respectively.
The principles of a good anastomosis are good vascular supply, must be tension-free, and the use of a high-quality surgical technique. The use of the OrVil(™) in laparoscopic upper-gastrointestinal surgery is safe and does not have an increased complication rate. It is quicker and easier compared to the traditional purse-string technique and it may help to expand the adoption of MIOG surgery.
越来越多的微创食管胃切除术(MIOG)正在进行。然而,所需的手术技能的复杂性和陡峭的学习曲线使得微创方法仅限于选定的三级中心。食管胃和食管空肠吻合术可能具有挑战性并且通常很耗时。最近开发的经口插入的吻合器(OrVil(™))是一种旨在简化吻合术的技术。本研究的目的是评估在我们的三级上消化道癌症中心的腹腔镜手术中使用 OrVil(™)辅助吻合术的安全性、可行性和疗效。
从 2008 年 7 月至 2010 年 7 月,我们的机构由一位外科医生对 53 例连续接受癌症微创胃切除术的患者进行了手术。30 例患者接受了腹腔镜 Ivor-Lewis 食管切除术(ILO),23 例患者接受了腹腔镜胃切除术。在后一组中,13 例患者接受了全胃切除术(TG),10 例患者接受了胃大部切除术(SG)。所有病例均在术中内镜检查胃肠吻合口。
有 3 例院内死亡。食管切除术的中位住院时间为 14 天,胃切除术的中位住院时间为 11 天。有 3 例吻合口漏(5.6%),均在食管组,经保守治疗成功治疗。2 例患者需要转为开腹手术(3.7%),3 例患者(5.6%)需要再次手术(因出血、感染性血肿和膈疝),18 例患者(34%)发生呼吸并发症(肺炎、胸腔积液、呼吸衰竭)。4 例患者发生吻合口狭窄,需要内镜球囊扩张。食管切除术和胃切除术的平均淋巴结清扫数分别为 22 个(范围为 11-39 个)和 26 个(范围为 5-78 个)。
良好吻合术的原则是良好的血管供应、无张力和使用高质量的手术技术。在腹腔镜上消化道手术中使用 OrVil(™)是安全的,并且不会增加并发症发生率。与传统的荷包技术相比,它更快、更容易,并且可能有助于扩大微创胃切除术的应用。